Topics

VIVA 2019: 4-Year Data Shows Success For Medtronic’s In.Pact Admiral DCB

08:09 EST 6 Nov 2019 | SCRIP

An ongoing trial of Medtronic’s In.Pact Admiral paclitaxel-coated balloon found a four-year survival rate in line with what would be...

      

Related Stories

 

Original Article: VIVA 2019: 4-Year Data Shows Success For Medtronic’s In.Pact Admiral DCB

NEXT ARTICLE

More From BioPortfolio on "VIVA 2019: 4-Year Data Shows Success For Medtronic’s In.Pact Admiral DCB"

Quick Search